Compare Western Alliance Bancorporation (WAL) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Western Alliance Bancorporation vs GeneDx Holdings Corp — how do they compare? Western Alliance Bancorporation trades at $79.8 (market cap $8.84B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Western Alliance Bancorporation is far larger — about 4.9× GeneDx Holdings Corp's market cap, and Western Alliance Bancorporation pays a 2.07% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| WAL | WGS | |
|---|---|---|
Market Cap | $8.84B | $1.80B |
Sector | Financials | Technology |
52-Week High | $96.08 | $167.51 |
52-Week Low | $66.70 | $34.51 |
Dividend Yield | 2.07% | — |
Enterprise Value | — | $1.80B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Western Alliance Bancorporation
Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.
Read more on WAL →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
